[ad_1]
Southwest Airlines Co.’s stock tumbled 10% premarket Wednesday, after the carrier lowered its second-quarter revenue guidance in a dynamic environment.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...